维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Downs LS Jr"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer显示文摘	Downs LS Jr Rogers LM Yokoyama Y	2006	Gynecol Oncol2006，98，2：	1
2	Cervical Cancer tests and treat- ment显示文摘	Carter JS Downs LS Jr	2011	Female Patient2011，36，1：	1
3	Aprospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenla PA		0，，02：	1
4	A phase I study ofifosfamide,paclitaxe,and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
5	Bevacizumab plus cyclophosphamide in heavily pretreated patients with recttrrent ovarian cancer 显示文摘	Chura JC Van Iseghem K Downs LS Jr	2007	Gynecol Oncol2007，107，2：	1
6	A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenta PA	2008	Cancer2008，112，2：	1
7	The influence of intraoperative rumor rapture on recurrence risk in Stage Ic epithelial ovarian cancer显示文摘	Goudge CS Li Z Downs LS Jr	2009	Eur J Gyrmecol Oncol2009，30，1：	1
8	A phase Ⅰ study of ifosfamide,paclitaxel;and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
9	A prospective randomized trial of tha- lidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian careinoma 显示文摘	Downs LS Jr Judson PL	2008	Cancer2008，112，2：	1
10	Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer显示文摘	Downs LS Jr Rogers LM Yokoyama Y	2005	Gynecol Oncol2005，98，：	1
11	A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenta PA		0，，02：	1
12	Thalidomide and angiostatin inhibit tumor growth in a routine xenograft model of human cervical cancer显示文摘	Downs LS Jr Rogers LM Yokoyama Y	2005	Gyneeol Oncol2005，98，2：	1
13	Bevacizumab plus cyclophosphamide in heavily pretreated patients with recur- rent ovarian cancer 显示文摘	Chura JC Van Iseghem K Downs LS Jr	2007	Gynecol Oncol2007，107，2：	1
14	Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer 显示文摘	Downs LS Jr Rogers LM Yokoyama Y	2005	Gynecol Oncol2005，98，2：	1
15	A prospective randomized trialof thalido- mide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL	2008	Cancer2008，112，2：	1
16	A prospective random- ized trim of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma 显示文摘	Downs LS Jr Judson PL Argenta PA	2008	Cancer2008，112，2：	1
17	Thalidomid-eand angiostatin inhibit tumor growth in a murine xenograftmodel of human cervical cancer显示文摘	Downs LS Jr Rogers LM Yokoyama Y etal	2005	Gynecol Oncol2005，98，：	1
18	Aprospective randomized trial of thalidomide with topotccan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenta PA	2008	Cancer2008，112，2：	1
19	A phase Ⅰ study of ifosfamide,paclitaxel,and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
20	Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer显示文摘	Chura JC Van Iseghem K Downs LS Jr	2007	Gynecol Oncol2007，107，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示